Braeburn Pharmaceutical’s President and CEO Discusses NC’s HB2 and Planned Facility

On this segment of Focus Washington, Chuck Conconi interviews President and CEO of Braeburn Pharmaceuticals, Behshad Sheldon, about the New Jersey based company’s intention to proceed with plans to develop a manufacturing and research facility in Durham County, North Carolina, despite the enactment of HB2, the controversial law that overturns local ordinances to prohibit discrimination against the LGBT community.

Sheldon has met with North Carolina Attorney General Roy Cooper, who shares the view that HB2 is unjust and needs to be overturned. However, the Attorney General argued that Braeburn could help more by advocating from within the state than by protesting through dropping plans to open the facility. The company states they have also been encouraged by the Department of Justice lawsuit filed on May 9, 2016 in NC Federal Court seeking a determination that HB2 violates federal non discrimination law, as well as the Obama administration’s guidelines issued to public schools on May 13, 2016.

Be the first to comment

Leave a Reply

Your email address will not be published.